Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
she did not receive the second dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 18th May 2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: she did not receive the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 04-AUG-2025 The consumer was the reporter. The reporter stated that her first dose of Shingrix was administered on 18th May 2023. Consumer stated she did not receive the second dose but will schedule an appointment to have the second dose administered which led to incomplete course of vaccination.